Stipple Bio, Inc. · CIK 1932776
Stipple Bio, Inc.
Filings
1
Original notices
1
Amendments
0
Activity
Apr 6, 2026
through Apr 6, 2026
through Apr 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Choose filings to compare · Research this issuer step by step
Latest available filing snapshot
- Reported offering amount
- $100,200,007
- Reported exemptions
- Rule 506(b)
- Reported amount sold
- $65,130,013
This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.
Related person name and locality match
Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.
- Bambusa Therapeutics, Inc. · CIK 2044950
Form D filings (1)
-
0001932776-26-000002D · Apr 6, 2026 · BiotechnologyOffering: $100,200,007Sold: $65,130,013